Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial
暂无分享，去创建一个
M. Rezai | P. Fasching | T. Fehm | C. Denkert | T. Kühn | C. Bokemeyer | H. Tesch | S. Loibl | K. Pantel | M. Untch | G. von Minckwitz | T. Karn | C. Schem | V. Müller | E. Vettorazzi | S. Loges | B. Rack | F. Holms | P. Krabisch | M. Janning | F. Overkamp | I. Ben-Batalla | M. Cubas-Cordova | K. Kittel | M. Just | Victoria Gensch | C. Zu Eulenburg | B. Schnappauf